J Askling Selected Research

J Askling Research Topics

Disease

10	Rheumatoid Arthritis 01/2018 - 10/2005
8	Lymphoma (Lymphomas) 01/2018 - 10/2005
8	Necrosis 02/2015 - 10/2005
6	Neoplasms (Cancer) 09/2017 - 10/2005
4	Rheumatic Diseases (Rheumatism) 01/2015 - 09/2005
3	Ankylosing Spondylitis 11/2018 - 09/2006
3	Ulcerative Colitis 09/2017 - 11/2006
3	Crohn Disease (Crohn's Disease) 09/2017 - 01/2014
2	Narcolepsy 01/2017 - 02/2014
2	Multiple Sclerosis 01/2016 - 04/2009
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2017
1	Relapsing-Remitting Multiple Sclerosis 01/2016
1	Heart Failure 08/2015
1	Autoimmune Diseases (Autoimmune Disease) 05/2015
1	Frailty 02/2015
1	Spondylarthropathies 01/2015
1	Hemochromatosis (Bronze Diabetes) 07/2012
1	Iron Overload 07/2012
1	Atherosclerosis 07/2012
1	Pain (Aches) 01/2011
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 12/2010
1	Arthritis (Polyarthritis) 12/2009
1	Lung Neoplasms (Lung Cancer) 12/2009
1	Epstein-Barr Virus Infections 04/2009
1	Infectious Mononucleosis (Glandular Fever) 04/2009
1	Vasculitis (Vasculitides) 05/2008
1	Systemic Vasculitis 05/2008
1	Inflammation (Inflammations) 11/2006
1	Appendicitis 11/2006
1	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 12/2005
1	Giant Cell Arteritis (Horton Disease) 12/2005
1	Melanoma (Melanoma, Malignant) 10/2005
1	Skin Neoplasms (Skin Cancer) 10/2005
1	Colorectal Neoplasms (Colorectal Cancer) 10/2005
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2004
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 10/2004

Drug/Important Bio-Agent (IBA)

9	Tumor Necrosis Factor InhibitorsIBA 01/2017 - 10/2005
3	Antirheumatic Agents (DMARD)IBA 11/2018 - 12/2009
3	Adalimumab (Humira)FDA Link 01/2017 - 01/2015
3	ORALIT (ORS)IBA 05/2015 - 10/2004
2	C-Reactive ProteinIBA 11/2018 - 01/2011
2	Methotrexate (Mexate)FDA LinkGeneric 01/2017 - 05/2014
2	Infliximab (Remicade)FDA Link 01/2017 - 02/2015
2	pandemrixIBA 01/2017 - 02/2014
2	Etanercept (Enbrel)FDA Link 02/2015 - 01/2015
2	ametantrone (HAQ)IBA 02/2015 - 01/2015
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	cyclic citrullinated peptideIBA 01/2018
1	Anti-Citrullinated Protein AntibodiesIBA 01/2018
1	AntibodiesIBA 01/2018
1	AutoantibodiesIBA 01/2018
1	Immunoglobulin A (IgA)IBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	Immunoglobulin M (IgM)IBA 01/2018
1	nitazoxanide (NTZ)FDA Link 01/2016
1	Natalizumab (Tysabri)FDA Link 01/2016
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2016
1	EtoricoxibIBA 08/2015
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 08/2015
1	Celecoxib (Celebrex)FDA Link 08/2015
1	Certolizumab Pegol FDA Link 01/2015
1	Prescription DrugsIBA 09/2014
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 05/2014
1	VaccinesIBA 02/2014
1	IronIBA 07/2012
1	Cytidine Diphosphate (CDP)IBA 12/2009
1	Abatacept (Orencia)FDA Link 12/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2009
1	HLA Antigens (Human Leukocyte Antigens)IBA 04/2009
1	HLA-DRB1 Chains (HLA DRB1)IBA 04/2009
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 05/2008
1	SteroidsIBA 12/2005
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2005
1	SmokeIBA 10/2005
1	Complement System Proteins (Complement)IBA 09/2005
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2004

Therapy/Procedure

6	Therapeutics 07/2017 - 05/2009
1	Ambulatory Care (Outpatient Care) 09/2017
1	Ambulatory Surgical Procedures (Outpatient Surgery) 01/2014
1	Biological Therapy 12/2010
1	Appendectomy 11/2006
1	Aftercare (After-Treatment) 10/2005